{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T14:00:11Z","timestamp":1765893611008,"version":"3.48.0"},"reference-count":32,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ningxia University Scientific Research Project","award":["NGY2020050"],"award-info":[{"award-number":["NGY2020050"]}]},{"name":"Ningxia key R & D program key project: basic research and clinical application of geriatric orthopedic diseases","award":["2018BEG02005"],"award-info":[{"award-number":["2018BEG02005"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,2,15]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Total knee arthroplasty (TKA) is a common and highly effective orthopaedic procedure for treating end-stage knee osteoarthritis. Tranexamic acid (TXA) has become a routine part of perioperative care in TKAs. The best practices regarding the delivery method of TXA in TKA remain controversial. Plasminogen activator inhibitor-1 (PAI-1), thrombin\u2013antithrombin (TAT) complexes and prothrombin fragment F1+2 (F1+2) have been demonstrated to be elevated in patients with venous thromboembolism (VTE). The aim of this trial was to investigate the most efficacious delivery method of TXA (comparison of intravenous and topical applications and comparison of three topical applications) and to evaluate the safety of TXA strategies by investigating the effect of TXA on the plasma D-dimer, PAI-1, TAT and F1+2 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and design<\/jats:title>\n                    <jats:p>This trial is a prospective, randomised, controlled study that will evaluate the efficacy and safety of strategies of TXA. A total of 250 patients undergoing primary TKA will be randomly allocated to five groups for different TXA applications. The primary outcome is total blood loss. The secondary outcomes are blood transfusion rate, drainage volume, plasma D-dimer, PAI-1, TAT and F1+2 levels, maximum haemoglobin drop, wound complications, VTE and length of hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study\u2019s protocol is in accordance with the declaration of Helsinki. The ethics committee of the General Hospital of Ningxia Medical University approved this study (approval ID: 2020\u2013505). The results of this study will be disseminated in international peer reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2000030624.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-038399","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T11:01:26Z","timestamp":1614337286000},"page":"e038399","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Prospective, randomised, controlled study on the efficacy and safety of different strategies of tranexamic acid with total blood loss, blood transfusion rate and thrombogenic biomarkers in total knee arthroplasty: study protocol"],"prefix":"10.1136","volume":"11","author":[{"given":"Yong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"},{"name":"Clinical college, Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"},{"name":"Clinical college, Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faxuan","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Public Health, Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinlong","family":"He","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Ding","sequence":"additional","affiliation":[{"name":"Clinical college, Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1901-7905","authenticated-orcid":false,"given":"Qunhua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of orthopedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"2025121605563385000_11.2.e038399.1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.F.00222"},{"key":"2025121605563385000_11.2.e038399.2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.thromres.2018.11.025","article-title":"Comparison of three routes of administration of tranexamic acid in primary unilateral total knee arthroplasty: analysis of a national database","volume":"173","author":"Xie","year":"2019","journal-title":"Thromb Res"},{"key":"2025121605563385000_11.2.e038399.3","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.N.00077"},{"key":"2025121605563385000_11.2.e038399.4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/trf.12918","article-title":"Transfusion-related adverse reactions reported to the National healthcare safety network Hemovigilance module, United States, 2010 to 2012","volume":"55","author":"Harvey","year":"2015","journal-title":"Transfusion"},{"key":"2025121605563385000_11.2.e038399.5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.injury.2014.11.032","article-title":"Association of perioperative blood transfusion and adverse events after operative treatment of proximal humerus fractures","volume":"46","author":"Kozanek","year":"2015","journal-title":"Injury"},{"key":"2025121605563385000_11.2.e038399.6","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.arth.2018.04.043","article-title":"The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"2025121605563385000_11.2.e038399.7","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.01518"},{"key":"2025121605563385000_11.2.e038399.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2014.03.032"},{"key":"2025121605563385000_11.2.e038399.9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2016.02.027","article-title":"Single-Dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: a double-blind, randomized controlled trial of different doses","volume":"141","author":"Wang","year":"2016","journal-title":"Thromb Res"},{"key":"2025121605563385000_11.2.e038399.10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024350"},{"key":"2025121605563385000_11.2.e038399.11","doi-asserted-by":"crossref","first-page":"230949901769352","DOI":"10.1177\/2309499017693529","article-title":"A randomized control trial to evaluate the effectiveness of intravenous, intra-articular and topical wash regimes of tranexamic acid in primary total knee arthroplasty","volume":"25","author":"Prakash","year":"2017","journal-title":"J Orthop Surg"},{"key":"2025121605563385000_11.2.e038399.12","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2106\/JBJS.19.00258","article-title":"Comparison of topical and intravenous tranexamic acid for total knee replacement","volume":"101","author":"Jules-Elysee","year":"2019","journal-title":"J Bone Joint Surg"},{"key":"2025121605563385000_11.2.e038399.13","doi-asserted-by":"crossref","first-page":"230949901986469","DOI":"10.1177\/2309499019864693","article-title":"Periarticular injection of tranexamic acid promotes early recovery of the range of knee motion after total knee arthroplasty","volume":"27","author":"Hirose","year":"2019","journal-title":"J Orthop Surg"},{"key":"2025121605563385000_11.2.e038399.14","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.arth.2019.12.018","article-title":"Response to Letter to the Editor on \"A Prospective Double-Blind Placebo Controlled Trial of Topical Tranexamic Acid in Total Knee Arthroplasty\"","volume":"35","author":"Georgiadis","year":"2020","journal-title":"J Arthroplasty"},{"key":"2025121605563385000_11.2.e038399.15","doi-asserted-by":"publisher","DOI":"10.1136\/rapm-2018-000024"},{"key":"2025121605563385000_11.2.e038399.16","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.arth.2016.04.036","article-title":"Intravenous vs topical tranexamic acid in total knee arthroplasty without tourniquet application: a randomized controlled study","volume":"31","author":"Tzatzairis","year":"2016","journal-title":"J Arthroplasty"},{"key":"2025121605563385000_11.2.e038399.17","first-page":"65","article-title":"Total knee replacement and imaging","volume":"87","author":"Scott","year":"2015","journal-title":"Radiol Technol"},{"key":"2025121605563385000_11.2.e038399.18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.arth.2017.10.016","article-title":"Changes in markers of thrombin generation and interleukin-6 during Unicondylar knee and total knee arthroplasty","volume":"33","author":"Su","year":"2018","journal-title":"J Arthroplasty"},{"key":"2025121605563385000_11.2.e038399.19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(01)00293-6","article-title":"Plasminogen activator inhibitor type-1 in cardiovascular disease. status report 2001","volume":"103 Suppl 1","author":"Huber","year":"2001","journal-title":"Thromb Res"},{"key":"2025121605563385000_11.2.e038399.20","doi-asserted-by":"publisher","DOI":"10.1177\/1076029616672585"},{"key":"2025121605563385000_11.2.e038399.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2015.05.034"},{"key":"2025121605563385000_11.2.e038399.22","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0268355519897552","article-title":"Correlation between PAI-1 rs1799889 polymorphism and venous thromboembolism: A meta-analysis of 48 case-control studies","volume":"35","author":"Geng","year":"2020","journal-title":"Phlebology"},{"key":"2025121605563385000_11.2.e038399.23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(12)62160-6"},{"key":"2025121605563385000_11.2.e038399.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2011.09.004"},{"key":"2025121605563385000_11.2.e038399.25","doi-asserted-by":"publisher","DOI":"10.5555\/uri:pii:0039606062901666"},{"key":"2025121605563385000_11.2.e038399.26","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/78.5.606"},{"key":"2025121605563385000_11.2.e038399.27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2106\/JBJS.17.00908","article-title":"Intravenous versus topical tranexamic acid in total knee arthroplasty: both effective in a randomized clinical trial of 640 patients","volume":"100","author":"Abdel","year":"2018","journal-title":"J Bone Jt Surg"},{"key":"2025121605563385000_11.2.e038399.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00402-015-2232-8"},{"key":"2025121605563385000_11.2.e038399.29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.knee.2017.11.006","article-title":"The comparative efficacy and safety of topical and intravenous tranexamic acid for reducing perioperative blood loss in total knee arthroplasty- a randomized controlled non-inferiority trial","volume":"25","author":"George","year":"2018","journal-title":"Knee"},{"key":"2025121605563385000_11.2.e038399.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2014.03.011"},{"key":"2025121605563385000_11.2.e038399.31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31791-x","article-title":"Tranexamic acid in primary total knee arthroplasty without tourniquet: a randomized, controlled trial of oral versus intravenous versus topical administration","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"2025121605563385000_11.2.e038399.32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.rbo.2016.09.012","article-title":"Comparative study of topical vs. intravenous tranexamic acid regarding blood loss in total knee arthroplasty","volume":"52","author":"Zekcer","year":"2017","journal-title":"Rev Bras Ortop"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-038399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:56:42Z","timestamp":1765893402000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-038399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,26]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bmjopen-2020-038399"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-038399","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}